Treating Critical Illness: The Importance of First Doing No Harm
Open Access
- 28 June 2005
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (6) , e167
- https://doi.org/10.1371/journal.pmed.0020167
Abstract
Singer and Glynne present evidence to suggest that the short- term benefits of many interventions for treating critical illness may camouflage an underlying tendency to cause harm.Keywords
This publication has 69 references indexed in Scilit:
- Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleedingBMJ, 2005
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrationsJournal of Clinical Anesthesia, 2004
- Early Alterations in the Number of Circulating Lymphocyte Subpopulations and Enhanced Proinflammatory Immune Response During Opioid-Based General AnesthesiaShock, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Frusemide or nitrates for acute heart failure?The Lancet, 1996
- Biochemical Characterization of the Effects of the Benzodiazepine, Midazolam, on Mitochondrial Electron TransferBasic & Clinical Pharmacology & Toxicology, 1996
- Mitochondrial biogenesis: Inhibitors of mitochondrial protein synthesisMolecular and Cellular Biochemistry, 1977